Treatment of Compulsive Hoarding - Full Text View

Purpose

This study will develop and test a cognitive behavioral treatment for compulsive accumulation of goods.

Condition	Intervention	Phase
Obsessive-Compulsive Disorder	Behavioral: Cognitive Behavioral Treatment	Phase I

MedlinePlus related topics:

Obsessive-Compulsive Disorder

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Historical Control, Parallel Assignment, Efficacy Study

Official Title:	Treatment of Compulsive Hoarding

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment:	52
Study Start Date:	September 2003
Estimated Study Completion Date:	August 2006

Detailed Description:

Compulsive hoarding is a form of obsessive-compulsive disorder (OCD) that is characterized by excessive acquisition of possessions, difficulty discarding possessions, and excessive clutter. This condition is resistant to both pharmacological and psychotherapeutic interventions that are effective in treating other symptoms of OCD. This study will determine the effectiveness of cognitive behavioral therapy (CBT) in treating compulsive hoarding symptoms.

This study consists of three phases. In Phase 1, data from previously conducted pilot studies will be revised and expanded. In Phase 2, the revised data will be used to develop and implement a treatment manual for compulsive hoarding. During this phase, treatment will be flexibly applied to allow for variations in treatment duration and choice of techniques. During Phase 3, participants will be randomly assigned to either CBT or a wait-list control, followed by active treatment for a fixed duration. Therapist adherence and competence will be assessed through audiotaped therapy sessions.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria:

Display at least moderately severe hoarding symptoms
Must live within 45 minutes of Boston, MA or Hartford, CT

Exclusion criteria:

Ten or more sessions of cognitive behavior therapy for hoarding
Concurrent psychotherapy or medications
Suicidal, psychotic, or other psychiatric symptoms requiring hospitalization
Compulsive buying symptoms that are part of a manic phase of bipolar disorder
Mental retardation, dementia, brain damage, or other cognitive dysfunction that would interfere with the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00073346

Locations


United States, Connecticut
	Hartford Hospital, Institute of Living
	Hartford, Connecticut, United States, 06106

United States, Massachusetts
	Boston University
	Boston, Massachusetts, United States, 02215

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

More Information

Click here for more information about compulsive hoarding. This link exits the ClinicalTrials.gov site

Study ID Numbers:	R21 MH68539, DATR A2-AIA
First Received:	November 19, 2003
Last Updated:	August 19, 2008
ClinicalTrials.gov Identifier:	NCT00073346
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):

Compulsive Hoarding

Study placed in the following topic categories:

Anxiety Disorders

Mental Disorders

Obsessive-Compulsive Disorder

ClinicalTrials.gov processed this record on November 20, 2008

Sponsored by:	National Institute of Mental Health (NIMH)
Information provided by:	National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:	NCT00073346